Ordeniza, Juncris P.

HRN: 20-79-98  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2024
CEFTRIAXONE 1G (VIAL)
01/01/2024
01/07/2024
IV
700mg
OD
T/c Septic Shock
Waiting Final Action 
01/01/2024
OXACILLIN 500MG (VIAL)
01/01/2024
01/08/2024
IV
180mg
Q6hours
Infected Colostomy Stump
Waiting Final Action 
01/01/2024
MUPIROCIN 2%, 15G (TUBE)
01/01/2024
01/08/2024
TOPICAL
Topical
BID
Infected Colostomy Site
Waiting Final Action 
01/01/2024
OXACILLIN 500MG (VIAL)
01/01/2024
01/08/2024
IV
300mg
Q6hours
Infected Colostomy Stump
Waiting Final Action 
01/02/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
01/02/2024
01/08/2024
PO
1ml
TID
Oral Ulcers
Waiting Final Action 
01/04/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/04/2024
01/11/2024
IV
54mg
Q8h
Septic Shock Sec To Infected Colostomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: